Publications by authors named "Kennedy S Werner"
Objective: Limited prospective data exist about the impact of stimulant therapy for attention-deficit hyperactivity disorder (ADHD) during adolescence on the risk for later prescription drug misuse (PDM; i.e., of benzodiazepines, opioids, and stimulants).
View Article and Find Full Text PDFBackground: To assess whether age of onset and duration of stimulant therapy for attention-deficit/hyperactivity disorder (ADHD) are associated with cocaine, methamphetamine, and prescription stimulant misuse during adolescence.
Methods: Nationally representative samples of US 10th and 12th grade students (N = 150,395) from the Monitoring the Future study were surveyed via self-administered questionnaires from 16 annual surveys (2005-2020).
Results: An estimated 8.
Background: Attention-deficit/hyperactivity disorder (ADHD) is associated with higher substance use rates. Stimulant and non-stimulant pharmacotherapy improve adolescent ADHD, but their associations with prescription stimulant misuse (PSM), cocaine, and methamphetamine use are unclear. Using 2005-2020 US Monitoring the Future data, we investigated relationships between ADHD pharmacotherapy history and PSM, cocaine, or methamphetamine use.
View Article and Find Full Text PDFArticle Synopsis
- The study explored how participation in different types of sports (high-contact, semi-contact, and noncontact) during 12th grade relates to the initiation and development of prescription drug misuse (PDM) from ages 17/18 to 27/28 years.
- It found that students involved in contact and noncontact sports were more likely to start misusing prescription stimulants later in life, with adjusted odds ratios indicating a significant increase in risk.
- This research is the first of its kind to link high school sports participation with PDM trends, highlighting the importance of screening for prescription drug misuse among teenagers and the need for ongoing monitoring in young adults, especially athletes.